1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) PatientsAdvanced Non Squamous NSCLC; Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Active, not recruitingPhase 1 / Phase 22026-01-16NCT06879717